Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MEDS will decline by -8.08% over the next 2 Weeks and hit $1.37 by Monday, August 31, 2026. In that time frame, MEDS's share price is expected to range between $0.80 and $1.97.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 31, 2026 | 0.80 | 1.37 | 1.97 |
| Aug 28, 2026 | 0.77 | 1.41 | 2.04 |
| Aug 27, 2026 | 0.59 | 1.20 | 1.85 |
| Aug 26, 2026 | 0.63 | 1.27 | 1.85 |
| Aug 25, 2026 | 0.79 | 1.41 | 2.02 |
| Aug 24, 2026 | 0.78 | 1.42 | 2.04 |
| Aug 21, 2026 | 0.81 | 1.46 | 2.13 |
| Aug 20, 2026 | 0.66 | 1.25 | 1.87 |
| Aug 19, 2026 | 0.68 | 1.32 | 1.94 |
| Aug 18, 2026 | 0.86 | 1.46 | 2.08 |
MEDS shares fell -3.69% in Tuesday, August 18, 2026's trading session, dropping from a previous close of $1.49 to move at $1.44. The stock demonstrated notable intraday movement (see MEDS's key stats for a full breakdown), fluctuating between $1.41 and $1.48, a +4.96% trading range. While recent weeks have seen some volatility, MEDS has managed to secure a -54.73% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 324.09K shares changing hands, 255.96K more than the previous session. This amounted to $465.07K in total market activity.
Will MEDS Continue Its Upward Trend?
According to analyst ratings and projections for MEDS, DataMEDS AI, Inc. shares are anticipated to increase by +27.03%, potentially reaching $1.97 per share by August 31, 2026. Short-term technical indicators currently suggest a neutral sentiment for MEDS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 10 positive trading days within the past 30 sessions. Based on the MEDS stock forecast, now is a good time to buy MEDS stock because its current trading price is +4.78% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MEDS covering social and institutional perspectives.
MEDS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MEDS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 25.77% to 34.01%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 39.87%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 44.33%, maintains a neutral outlook for the long term. Insights into MEDS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
DataMEDS AI Short-Term Forecasts
MEDS Forecast For Next 5 Days
Our algorithm anticipates DataMEDS AI (MEDS) stock could hit $1.37 by Aug 25, 2026. This represents a -4.24% rise from today's price, following a +3.14% change over the past five days.
MEDS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for DataMEDS AI, Inc. (MEDS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.39, which would mean a -3.14% decrease from the current price of $1.44. Projections for this period range from a high of $2.23 to a low of $0.60.
MEDS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for DataMEDS AI's price over the next three months point to a drop. MEDS stock is expected to peak at $1.62 on Aug 19, 2026 before potentially dipping to $0.00 on Nov 18, 2026. On average, MEDS is likely to trade around $0.37 in the coming 90 days.
DataMEDS AI Stock Forecast 2025
Based on our predictive models, DataMEDS AI (MEDS) is expected to trade between $0.00 and $1.62 throughout 2026. This would result in an average price of $0.32, potentially offering investors a -77.70% return from current levels.
DataMEDS AI, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, DataMEDS AI, Inc. (MEDS) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $1.62, settling at an average of $0.51. This could translate to a -64.46% loss.
September 2026
Based on current market signals, DataMEDS AI, Inc. is projected to trend september 2026. We forecast a trading range from $0.00 to $1.45, with a likely average price of $0.36. Investors could expect a potential return of -74.91%.
October 2026
Our predictive algorithms indicate DataMEDS AI, Inc. stock may see a shift in October 2026. The expected range spans $0.00–$1.56, with an average target of $0.38. This represents a cautious outlook and a possible loss of -73.52%.
November 2026
Analyzing established trends, DataMEDS AI, Inc. looks set to move in November 2026. Projections place the stock between $0.00 and $1.45, averaging around $0.26. This suggests a -81.88% loss from current levels.
December 2026
Market indicators suggest DataMEDS AI, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $1.29, with a midpoint forecast of $0.20. The stock might deliver a -86.06% loss.
January 2027
Forecasting for January 2027, models estimate that DataMEDS AI, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.38, averaging $0.16. This signals a cautious trajectory with potential returns around -88.85%.
February 2027
According to our latest forecast models, DataMEDS AI, Inc. (MEDS) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $1.17, settling at an average of $0.11. This could translate to a -92.33% loss.
March 2027
Based on current market signals, DataMEDS AI, Inc. is projected to trend march 2027. We forecast a trading range from $0.00 to $1.24, with a likely average price of $0.16. Investors could expect a potential return of -88.85%.
April 2027
Our predictive algorithms indicate DataMEDS AI, Inc. stock may see a shift in April 2027. The expected range spans $0.00–$1.25, with an average target of $0.12. This represents a cautious outlook and a possible loss of -91.64%.
May 2027
Analyzing established trends, DataMEDS AI, Inc. looks set to move in May 2027. Projections place the stock between $0.00 and $1.20, averaging around $0.10. This suggests a -93.03% loss from current levels.
June 2027
Market indicators suggest DataMEDS AI, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $1.27, with a midpoint forecast of $0.10. The stock might deliver a -93.03% loss.
July 2027
Forecasting for July 2027, models estimate that DataMEDS AI, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.16, averaging $0.10. This signals a cautious trajectory with potential returns around -93.03%.
August 2027
According to our latest forecast models, DataMEDS AI, Inc. (MEDS) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $1.16, settling at an average of $0.10. This could translate to a -93.03% loss.
MEDS's history of dividends and stock splits also plays a role in long-term investor confidence.